I agree that this site is using cookies. You can find further informations here.
X
Chiappori, Alberto A
155  results:
Search for persons X
?
1

Phase 2 Trial of Nivolumab and Ramucirumab for Relapsed Mes..:

Dudek, Arkadiusz Z. ; Xi, Min X. ; Scilla, Katherine A....
JTO Clinical and Research Reports.  4 (2023)  12 - p. 100584 , 2023
Link: https://doi.org/10.1016/..
 
?
2

A phase I/IB trial of binimetinib in combination with erlot..:

Saltos, Andreas N. ; Creelan, Ben C. ; Tanvetyanon, Tawee...
Lung Cancer.  183 (2023)  - p. 107313 , 2023
Link: https://doi.org/10.1016/..
 
?
3

Dose-Limiting Pulmonary Toxicity in a Phase 1/2 Study of Ra..:

Liveringhouse, Casey L. ; Latifi, Kujtim ; Asous, Amalin G....
International Journal of Radiation Oncology*Biology*Physics.  116 (2023)  4 - p. 837-848 , 2023
Link: https://doi.org/10.1016/..
 
?
4

Treatment Strategies for Non-Small Cell Lung Cancer with Co..:

Marin-Acevedo, Julian A. ; Pellini, Bruna ; Kimbrough, ErinMarie O...
Cancers.  15 (2023)  3 - p. 629 , 2023
Link: https://doi.org/10.3390/..
 
?
5

Early Adverse Event Derived Biomarkers in Predicting Clinic..:

Chen, Dung-Tsa ; Saltos, Andreas N. ; Rose, Trevor...
Cancers.  15 (2023)  9 - p. 2521 , 2023
Link: https://doi.org/10.3390/..
 
?
6

First-in-human study of an OX40 (ivuxolimab) and 4-1BB (uto..:

Hamid, Omid ; Chiappori, Alberto A ; Thompson, John A...
Journal for ImmunoTherapy of Cancer.  10 (2022)  10 - p. e005471 , 2022
Link: https://doi.org/10.1136/..
 
?
7

Prospective Single-Arm Phase 1 and 2 Study: Ipilimumab and ..:

Perez, Bradford A. ; Kim, Sungjune ; Wang, Minhsuan...
International Journal of Radiation Oncology*Biology*Physics.  109 (2021)  2 - p. 425-435 , 2021
Link: https://doi.org/10.1016/..
 
?
8

Notch signaling and efficacy of PD-1/PD-L1 blockade in rela..:

Roper, Nitin ; Velez, Moises J. ; Chiappori, Alberto...
Nature Communications.  12 (2021)  1 - p. , 2021
Link: https://doi.org/10.1038/..
 
?
9

Tumor-infiltrating lymphocyte treatment for anti-PD-1-resis..:

Creelan, Benjamin C. ; Wang, Chao ; Teer, Jamie K....
Nature Medicine.  27 (2021)  8 - p. 1410-1418 , 2021
Link: https://doi.org/10.1038/..
 
?
10

Utilization of target lesion heterogeneity for treatment ef..:

Chen, Dung-Tsa ; Chan, Wenyaw ; Thompson, Zachary J....
PLOS ONE.  16 (2021)  7 - p. e0252041 , 2021
Link: https://doi.org/10.1371/..
 
?
11

Preclinical evaluation of [225Ac]Ac-DOTA-TATE for treatment..:

Tafreshi, Narges K. ; Pandya, Darpan N. ; Tichacek, Christopher J....
European Journal of Nuclear Medicine and Molecular Imaging.  48 (2021)  11 - p. 3408-3421 , 2021
Link: https://doi.org/10.1007/..
 
?
12

Three-Year Overall Survival with Durvalumab after Chemoradi..:

Gray, Jhanelle E. ; Villegas, Augusto ; Daniel, Davey...
Journal of Thoracic Oncology.  15 (2020)  2 - p. 288-293 , 2020
Link: https://doi.org/10.1016/..
 
?
13

Randomized Phase II Study of Paclitaxel plus Alisertib vers..:

Owonikoko, Taofeek K. ; Niu, Huifeng ; Nackaerts, Kristiaan...
Journal of Thoracic Oncology.  15 (2020)  2 - p. 274-287 , 2020
Link: https://doi.org/10.1016/..
 
?
14

Update on the Biology, Management, and Treatment of Small C..:

Saltos, Andreas ; Shafique, Michael ; Chiappori, Alberto
Frontiers in Oncology.  10 (2020)  - p. , 2020
Link: https://doi.org/10.3389/..
 
?
15

Safety, tolerability and immunogenicity of V934/V935 hTERT ..:

Aurisicchio, Luigi ; Fridman, Arthur ; Mauro, David...
Journal of Translational Medicine.  18 (2020)  1 - p. , 2020
Link: https://doi.org/10.1186/..
 
1-15